|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.944 USD | +4.01% |
|
+6.26% | -57.19% |
| Jun. 20 | SAB Biotherapeutics, Inc. has Changed its Name to SAB BIO | CI |
| Jun. 07 | Brookline Capital Initiates SAB Biotherapeutics With Buy Rating, $8 Price Target | MT |
On June 20, 2024, SAB Biotherapeutics, Inc. changed its name to SAB BIO.
| 1st Jan change | Capi. | |
|---|---|---|
| -57.19% | 26.12M | |
| +16.44% | 122B | |
| +20.12% | 115B | |
| +21.22% | 26.64B | |
| -23.31% | 19.91B | |
| -17.47% | 16.32B | |
| -45.95% | 15.52B | |
| -19.04% | 15.49B | |
| +61.69% | 14.83B | |
| +3.18% | 13.67B |
SAB BIOTHERAPEUTICS, INC. 
